Takeaway

• The majority of children and adolescents living with HIV in the real world achieved rapid viral load suppression (VLS) with dolutegravir, with improvements maintained for up to 2-3 years.

Why this matters

• Dolutegravir-based antiretroviral therapy (ART) has been a preferred treatment regimen for children and adolescents living with HIV.
• Recent...